Publications
5891 Results
- Journal / Conference
- Breast Cancer Research and Treatment, 130(3):993-1002;
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221) [PMID21766209; PMC33532924]
- Journal / Conference
- American Society of Preventive Oncology Annual Meeting 2011, poster presentation
- Year
- 2011
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Study transition from local in-person follow-up to centralized follow-up by mail
- Journal / Conference
- American Society of Preventive Oncology Annual Meeting 2011, poster presentation
- Year
- 2011
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
The consent process for transitioning a large trial to centralized follow-up
- Journal / Conference
- American Journal of Epidemiology 173(12):1429-1439;
- Year
- 2011
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Serum phospholipid fatty acids and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID21518693; PMC3145396
- Journal / Conference
- Journal of Clinical Oncology, 29(34):4555-4560; 2011 Oct 24 [Epub ahead of print];
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0356
S0356: A phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma [PMID22025151;PMC3236655]
- Journal / Conference
- Clinical Colorectal Cancer 10(4):310-316;
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9041
Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions [PMID21782524;NIHMS326411]
- Journal / Conference
- Blood 118(3):523-528;
- Year
- 2011
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0605
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: SWOG study S0605
- Journal / Conference
- Journal of Clinical Oncology 29: 2011 (suppl; abstr 1004); ASCO 2011 meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
First analysis of SWOG S0221: A phase III trial comparing chemotherapy schedules in high risk early breast cancer
- Journal / Conference
- Journal of Clinical Oncology 29: 2011 (suppl; abstr TPS104); ASCO Meeting, TIP poster
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S1007
SWOG S1007: a phase III, randomized clinical trial of standard adjuvant endocrine therapy +/- chemotherapy in patients with 1-2 positive nodes, hormone receptor (HR)-positive and HER2-negative breast cancer with recurrence score (RS) of 25 or less
- Journal / Conference
- Journal of Clinical Oncology 29: 2011 (suppl; abstr 7040); ASCO 2011 meeting, general poster presentation
- Year
- 2011
- Research Committee(s)
- Lung
- Study Number(s)
- S0429